A G E N D A

 

 

The National Collegiate Athletic Association

 

Committee on Competitive Safeguards and Medical Aspects of Sports

 

Drug-Education and Drug-Testing Subcommittee

 

 

NCAA National Office

December 15, 2002

Indianapolis, Indiana

 

 

1.      Introduce new members and review agenda.  (Rochel Rittgers)

 

 

2.             Approve June 21-23 meeting minutes.  [Supplement No. 1]  (Rittgers)

 

 

3.             Review strategic plan.  [Refer to Supplement No. 3 in the Committee on Competitive Safeguards and Medical Aspects of Sports (CSMAS) agenda]

 

 

4.             Follow up on recent relevant governance actions.  [Supplement No. 2]  (Rittgers)

 

 

5.             Report from The National Center for Drug Free Sport (The Center).  [Supplement No. 3 to be distributed at the meeting.]  (Frank Uryasz and Andrea Wickerham)

 

 

6.             Identify changes to banned substance list.  [Supplement No. 4]

 

 

7.             Recommend drug-testing protocol changes.  [Supplement No. 5]  (Elsa Cole)

 

 

8.             Appeal process.  [Supplement No. 6]  (Rittgers)

 

 

9.             Medical exception process.  [Supplement No. 7]  (Cole, Lauren Costello and Arnold Mazur)

 

 

10.         Drug testing forms.  [Supplement  No. 8]

 

a.             Consent form.  [Supplement No. 9]

b.             Student-athlete statement.  [Supplement No. 10]


11.         Drug-testing issues.

 

a.             Drug-testing program evaluation update.  (Uryasz and Wickerham)

 

b.             Accepting outside drug-testing sanctions and review of WADA Code.  (Cole, Costello, Mazur and Matt Mitten)  [Supplement No. 11]

c.             Graded penalties update.  [Supplement No. 12]  (Costello and Mazur)

d.             Second positive test sanction.  [Supplement No. 13]

e.             Other.  [Supplement No. 14]

 

12.         Alcohol issues.

 

a.             Techniques for Effective Alcohol Management (TEAM) on Campus update.  [Supplement No. 15 to be distributed at the meeting]

 

b.             Fall 2002 Speakers Grants.  [Supplement No. 16]

 

c.             Athletic Prevention Programming and Leadership Education (APPLE) conferences proposal.  [Supplement No. 17]

 

d.             CHOICES 2003 and proposal for 2004.  [Supplement No. 18] 

 

e.             Betty Ford Professional-in-Residence Program.

 

(1)   Applicants for 2003.  [Supplement No. 19]

(2)   Proposal for extended experience.  [Supplement No. 20]

 

 

13.         Tobacco issues.

 

a.             Centers for Disease Control (CDC), and BACCHUS and GAMMA 2nd National Collegiate Tobacco Symposium.  [Supplement No. 21]

b.             Tobacco companies partnering with sports organizations.  [Supplement No. 22]

 

c.             CDC efforts.  [Supplement No. 23]

 


14   Nutritional supplements issues.

a.      Red Bull.  [Supplement No. 24]

b.         Manufacturers claims and affiliations.  [Supplement No. 25]

c.         Congressional testimony on ephedra.  [Supplement No. 26]  (Uryasz)

d.         ZMA study.  [Supplement No. 27]

e.         Nutritional Supplement Advisory.  [Supplement No. 28]

 

 

15.     Other drug issues.

a.      Athletes Training and Learning About Steroids (ATLAS).  [Supplement No. 29]

b.      Choices in Sports Web site.  [Supplement No. 30]

 

16.     Outreach opportunities.

a.             Inter-Association Task Force (IATF).  [Supplement No. 31]

 

b.             U.S. Department of Education National Meeting.  [Supplement No. 32]

 

c.             Hormone Foundation.  [Supplement No. 33]

 

 

17.            Research data and opportunities.

 

a.             2003 Drug-Education/Drug-Testing (DEDT) Survey.  [Supplement No. 34]  (Todd Petr)

 

b.             2004 Survey of Substance Use Habits of College Student-Athletes.  [Supplement No. 35] 

 

c.             University of California, Los Angeles Erythropoetin study.  [Supplement No. 36]

 

 

18.     DEDT legislation concerning nutritional supplements.  [Supplement No. 37]  (Abe Frank)

 

 

19.     Review drug-education budget for reallocation.  [Supplement No. 38]

a.      Adjustments.  [Supplement No. 39]


b.      Banned drug wallet cards.  [Supplement No. 40]

c.         DEDT video.

 

 

20.         Recommend topics and articles for Health and Safety Newsletter.

 

 

21.     Articles of interest.  [Supplement No. 41]

a.       U.K. Could Have Cannabis-Based Medicine by 2004.

b.       AMA Calls for Ephedra Ban.

c.       FDA Bans Ephedra Imports.

 

 

22.     Sports Sciences Safety Subcommittee Agenda.  [Supplement No. 42]

 

23.     Other issues.

 

24.   Adjournment.